TURKEL CATHERINE C. has filed 5 insider transactions across 1 company since February 2023.
Most recent transaction: a purchase of 1600 shares of Lexaria Bioscience Corp. ($LEXX) on August 12, 2024.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2024 | Lexaria Bioscience Corp. | $LEXX | TURKEL CATHERINE C. | Director | P | common shares | 1600 | $3.13 | 4,600.0000 | 0 | 53.33% | 0.00% |
| July 26, 2024 | Lexaria Bioscience Corp. | $LEXX | TURKEL CATHERINE C. | Director | A | Stock Options | 12000 | $0.00 | 60,400.0000 | 0 | 24.79% | 0.00% |
| April 26, 2024 | Lexaria Bioscience Corp. | $LEXX | TURKEL CATHERINE C. | Director | A | Stock Options | 5000 | $0.00 | 33,400.0000 | 0 | 17.61% | 0.00% |
| July 25, 2023 | Lexaria Bioscience Corp. | $LEXX | TURKEL CATHERINE C. | Director | A | Stock Options | 5000 | $0.00 | 18,400.0000 | 0 | 37.31% | 0.00% |
| Feb. 9, 2023 | Lexaria Bioscience Corp. | $LEXX | TURKEL CATHERINE C. | Director | P | Common Shares | 1500 | $2.84 | 1,500.0000 | 0 | 9999.99% | 0.00% |